Source - LSE Regulatory
RNS Number : 6712K
Competition and Markets Authority
17 April 2024
Reference to a Phase 2 investigation: Spreadex / Sporting Index
On 4 April 2024, the CMA decided that it was or may be the case that the above Merger has resulted in a substantial lessening of competition (SLC) within a market or markets in the United Kingdom.
Pursuant to section 73A(1) of the Act, Spreadex had until 11 April 2024 to offer an undertaking to the CMA that might be accepted by the CMA under section 73(2) of the Enterprise Act 2004 (the Act). On 10 April 2024, Spreadex informed the CMA that it would not be offering any undertakings. The CMA has therefore decided to refer this Merger for a phase 2 investigation pursuant to sections 22 and 34ZA(2) of the Act.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
